Author:
Chang Cheng,Tang Xin,Woodley David T.,Chen Mei,Li Wei
Funder
Congressionally Directed Medical Research Programs
National Institutes of Health
Reference63 articles.
1. U.S. FDA, Oncology (Cancer) / Hematologic Malignancies Approval Notifications. https://www.fda.gov/drugs/resources-information-approved-drugs/oncology-cancer-hematologic-malignancies-approval-notifications. Accessed April 17, 2024.
2. Update on Hsp90 inhibitors in clinical trial;Kim;Curr Top Med Chem,2009
3. Targeting the dynamic HSP90 complex in cancer;Trepel;Nat Rev Cancer,2010
4. Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers;Jhaveri;Biochim Biophys Acta,2011
5. Hsp90 molecular chaperone inhibitors: are we there yet?;Neckers;Clin Cancer Res,2012